UNSPSC 51352009: Norethynodrel or noretynodrel

This classification denotes a therapeutic progestin with the molecular formula C20H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 88181ACA0M, chemically known as 19-norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-, (17.alpha.)- but generally known as norethynodrel, which bears US NIH Compound Identifier 4537. European Medicines Agency schedules Noretynodrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12439MIG.

The term NORETYNODREL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). Norethynodrel or noretynodrel bears US NLM identifiers UMLS ID C0028360 and NCI Concept Code C66244. SMILES: CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCC(=O)C4.

UNSPSC 51352009 Norethynodrel or noretynodrel, a Commodity code, addresses a narrow pharmaceutical active ingredient used in oral contraceptive formulations. State and local health departments, correctional facilities, and public health clinics procure this ingredient or finished-dosage products containing it to support family planning, reproductive health, and inmate healthcare programs. The code encompasses both the raw pharmaceutical active ingredient for institutional compounding and pre-manufactured oral contraceptive tablets or capsules containing norethynodrel. Issuing bodies include state departments of health, county health authorities, municipal public health clinics, and correctional departments at state and county levels.

The most recent state and local contract opportunities block contains no active solicitations under this code. Procurement activity in pharmaceutical contraceptive ingredients and finished goods is typically bundled under broader family-planning or pharmacy-supply codes, or issued as standing orders through cooperative purchasing agreements rather than discrete competitive RFPs. State and local governments access norethynodrel-containing products through established vendor relationships, group purchasing organizations, and federally qualified health center supply chains. Without recent activity visible in the opportunities record, pursuit under this specific code should be weighted against broader reproductive health and pharmacy-supply categories where state and local demand is more readily signaled through active solicitations.